These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 26868507)

  • 21. Effect of simvastatin or its combination with ezetimibe on Toll-like receptor expression and lipopolysaccharide - induced cytokine production in monocytes of hypercholesterolemic patients.
    Moutzouri E; Tellis CC; Rousouli K; Liberopoulos EN; Milionis HJ; Elisaf MS; Tselepis AD
    Atherosclerosis; 2012 Dec; 225(2):381-7. PubMed ID: 23062767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LDL-C goal attainment with the addition of ezetimibe to ongoing simvastatin treatment in coronary heart disease patients with hypercholesterolemia.
    Brohet C; Banai S; Alings AM; Massaad R; Davies MJ; Allen C
    Curr Med Res Opin; 2005 Apr; 21(4):571-8. PubMed ID: 15899106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the effect of simvastatin versus simvastatin/ezetimibe versus rosuvastatin on markers of inflammation and oxidative stress in subjects with hypercholesterolemia.
    Moutzouri E; Liberopoulos EN; Tellis CC; Milionis HJ; Tselepis AD; Elisaf MS
    Atherosclerosis; 2013 Nov; 231(1):8-14. PubMed ID: 24125402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study).
    Robinson JG; Ballantyne CM; Hsueh W; Rosen J; Lin J; Shah A; Lowe RS; Hanson ME; Tershakovec AM
    J Clin Lipidol; 2011; 5(6):474-82. PubMed ID: 22108151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ezetimibe and simvastatin combination inhibits and reverses the pro-inflammatory and pro-atherogenic effects of cream in obese patients.
    Ghanim H; Green K; Abuaysheh S; Patel R; Batra M; Chaudhuri A; Makdissi A; Kuhadiya ND; Dandona P
    Atherosclerosis; 2017 Aug; 263():278-286. PubMed ID: 28711708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ezetimibe/simvastatin vs atorvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia: the VYTAL study.
    Goldberg RB; Guyton JR; Mazzone T; Weinstock RS; Polis A; Edwards P; Tomassini JE; Tershakovec AM
    Mayo Clin Proc; 2006 Dec; 81(12):1579-88. PubMed ID: 17165637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term safety and, tolerability profiles and lipid-modifying efficacy of ezetimibe coadministered with ongoing simvastatin treatment: a multicenter, randomized, double-blind, placebo-controlled, 48-week extension study.
    Masana L; Mata P; Gagné C; Sirah W; Cho M; Johnson-Levonas AO; Meehan A; Troxell JK; Gumbiner B;
    Clin Ther; 2005 Feb; 27(2):174-84. PubMed ID: 15811480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ezetimibe/simvastatin.
    Montecucco F; Quercioli A; Mach F
    Expert Opin Drug Saf; 2009 Nov; 8(6):715-25. PubMed ID: 19968571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of co-administering ezetimibe with on-going simvastatin treatment on LDL-C goal attainment in hypercholesterolemic patients with coronary heart disease.
    Farnier M; Volpe M; Massaad R; Davies MJ; Allen C
    Int J Cardiol; 2005 Jul; 102(2):327-32. PubMed ID: 15982505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of low-dose simvastatin and ezetimibe compared to high-dose simvastatin alone on post-fat load endothelial function in patients with metabolic syndrome: a randomized double-blind crossover trial.
    Olijhoek JK; Hajer GR; van der Graaf Y; Dallinga-Thie GM; Visseren FL
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):145-50. PubMed ID: 18670365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reduction.
    Toth PP; Ballantyne CM; Davidson MH; Tomassini JE; Ramey DR; Neff D; Tershakovec AM; Hu XH; Tunceli K
    J Clin Lipidol; 2012; 6(2):180-91. PubMed ID: 22385552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans.
    Landmesser U; Bahlmann F; Mueller M; Spiekermann S; Kirchhoff N; Schulz S; Manes C; Fischer D; de Groot K; Fliser D; Fauler G; März W; Drexler H
    Circulation; 2005 May; 111(18):2356-63. PubMed ID: 15867181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of simvastatin treatment on sICAM-1 and sE-selectin levels in hypercholesterolemic subjects.
    Sardo MA; Castaldo M; Cinquegrani M; Bonaiuto M; Maesano A; Schepis F; Zema MC; Campo GM; Squadrito F; Saitta A
    Atherosclerosis; 2001 Mar; 155(1):143-7. PubMed ID: 11223435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does Metformin Protect Diabetic Patients from Oxidative Stress and Leukocyte-Endothelium Interactions?
    Diaz-Morales N; Rovira-Llopis S; Bañuls C; Lopez-Domenech S; Escribano-Lopez I; Veses S; Jover A; Rocha M; Hernandez-Mijares A; Victor VM
    Antioxid Redox Signal; 2017 Dec; 27(17):1439-1445. PubMed ID: 28467723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age may determine the effect of hypolipidemic agents on plasma adipokine levels in patients with elevated low-density lipoprotein cholesterol levels.
    Krysiak R; Żmuda W; Marek B; Okopień B
    Endokrynol Pol; 2016; 67(3):271-6. PubMed ID: 26884289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of ezetimibe on androgen production in hypercholesterolemic women with polycystic ovary syndrome.
    Krysiak R; Zmuda W; Okopien B
    Cardiovasc Ther; 2014 Oct; 32(5):219-23. PubMed ID: 25056604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia.
    Ballantyne CM; Blazing MA; King TR; Brady WE; Palmisano J
    Am J Cardiol; 2004 Jun; 93(12):1487-94. PubMed ID: 15194018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mitochondrial antioxidant SS-31 increases SIRT1 levels and ameliorates inflammation, oxidative stress and leukocyte-endothelium interactions in type 2 diabetes.
    Escribano-Lopez I; Diaz-Morales N; Iannantuoni F; Lopez-Domenech S; de Marañon AM; Abad-Jimenez Z; Bañuls C; Rovira-Llopis S; Herance JR; Rocha M; Victor VM
    Sci Rep; 2018 Oct; 8(1):15862. PubMed ID: 30367115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular and metabolic effects of ezetimibe combined with simvastatin in patients with hypercholesterolemia.
    Koh KK; Oh PC; Sakuma I; Kim EY; Lee Y; Hayashi T; Han SH; Park YM; Shin EK
    Int J Cardiol; 2015 Nov; 199():126-31. PubMed ID: 26188833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.